Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Balance Sheet and Related Statements of Operations and Cash Flows (Tables)

v3.8.0.1
Restatement of Condensed Consolidated Balance Sheet and Related Statements of Operations and Cash Flows (Tables)
3 Months Ended
Mar. 31, 2017
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement

The impact of this change for the three month period ended March 31, 2017 is as follows (in thousands, except share and per share data):

 

    Three months ended March 31, 2017  
   

As Previously

Reported

    As Restated  
Total other income (expense), net   $ (348 )   $ 1,290  
Total net loss     (2,150 )     (512 )
Deemed dividend related to beneficial conversion feature and accretion of a discount on Series A Preferred Stock     -       -  
Net loss attributable to common stockholders   $ (2,150 )   $ (512 )
Net loss per share attributable to common stockholders: 
Basic and diluted
  $ (0.06 )   $ (0.18 )
Weighted average common shares outstanding: 
Basic and diluted
    2,826,469       2,826,469  
 Common stock, $0.01 par value   $ 30     $ 30  
Additional paid-in capital     231,345       225,432  
Accumulated deficit     (215,285 )     (211,511 )
Total stockholders’ equity   $ 16,090     $ 13,911  
Derivative liabilities, current portion   $ -     $ 2,179